# Chest Tube-Delivered Bupivacaine to Decrease Postoperative Pain After Cardiac Surgery

> **NCT07643506** · EARLY_PHASE1 · NOT_YET_RECRUITING · sponsor: **University of Calgary** · enrollment: 60 (estimated)

## Conditions studied

- Coronary Artery Bypass Graft (CABG)
- Chest Tubes
- Post Operative Pain Control

## Interventions

- **DRUG:** 0.5% Bupivacaine without epinephrine
- **DRUG:** 10cc injection of normal saline (0.9%)

## Key facts

- **NCT ID:** NCT07643506
- **Lead sponsor:** University of Calgary
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-15
- **Primary completion:** 2027-06-30
- **Final completion:** 2028-06-30
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-06-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07643506

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07643506, "Chest Tube-Delivered Bupivacaine to Decrease Postoperative Pain After Cardiac Surgery". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07643506. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*